Literature DB >> 19903178

Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease.

S Cialfi1, C Oliviero, S Ceccarelli, C Marchese, L Barbieri, G Biolcati, D Uccelletti, C Palleschi, L Barboni, C De Bernardo, P Grammatico, A Magrelli, M Salvatore, D Taruscio, L Frati, A Gulino, I Screpanti, C Talora.   

Abstract

BACKGROUND: Hailey-Hailey disease (HHD) is an autosomal dominant disorder characterized by suprabasal cutaneous cell separation (acantholysis) leading to the development of erosive and oozing skin lesions. While a strong relationship exists between mutations in the gene that encodes the Ca(2+)/Mn(2+)-adenosine triphosphatase ATP2C1 and HHD, we still have little understanding of how these mutations affect manifestations of the disease.
OBJECTIVES: This study was designed to determine early signalling events that affect epithelial cell growth and differentiation during HHD development.
METHODS: Expression of key regulatory signals important for maintaining skin homeostasis were evaluated by Western blot analysis and by reverse transcriptase-polymerase chain reaction in primary keratinocytes obtained from skin biopsies of patients with HHD. Reactive oxygen species accumulation in primary keratinocytes derived from lesional skin of patients with HHD was assessed by dihydrorhodamine 123 (DHR) assay.
RESULTS: HHD-derived keratinocytes showed downregulation of both Notch1 and differential regulation of different p63 isoforms. Itch and p63 are co-expressed in the epidermis and in primary keratinocytes where Itch controls the p63 protein steady-state level. We found that the Itch protein was significantly decreased in HHD-derived keratinocytes whereas the expression of its target, c-Jun, remained unaffected. We also found that HHD-derived keratinocytes undergo oxidative stress, which may explain both Notch1 and Itch downregulation.
CONCLUSIONS: Our attempt to explore the molecular mechanism underlying HHD indicates a complex puzzle in which multi-hit combinations of altered signal pathways may explain the wide spectrum of defects in HHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903178     DOI: 10.1111/j.1365-2133.2009.09500.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 2.  The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus.

Authors:  Ilse Vandecaetsbeek; Peter Vangheluwe; Luc Raeymaekers; Frank Wuytack; Jo Vanoevelen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

3.  Two patients with Hailey-Hailey disease, multiple primary melanomas, and other cancers.

Authors:  Melinda R Mohr; Gulsun Erdag; Amber L Shada; Michael E Williams; Craig L Slingluff; James W Patterson
Journal:  Arch Dermatol       Date:  2011-02

4.  Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.

Authors:  Samantha Cialfi; Rocco Palermo; Sonia Manca; Carlo De Blasio; Paula Vargas Romero; Saula Checquolo; Diana Bellavia; Daniela Uccelletti; Michele Saliola; Angelo D'Alessandro; Lello Zolla; Alberto Gulino; Isabella Screpanti; Claudio Talora
Journal:  Cell Cycle       Date:  2014-05-06       Impact factor: 4.534

Review 5.  The role of microRNAs in the biology of rare diseases.

Authors:  Marco Salvatore; Armando Magrelli; Domenica Taruscio
Journal:  Int J Mol Sci       Date:  2011-10-11       Impact factor: 5.923

6.  The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα.

Authors:  P Vargas Romero; S Cialfi; R Palermo; C De Blasio; S Checquolo; D Bellavia; S Chiaretti; R Foà; A Amadori; A Gulino; G Zardo; C Talora; I Screpanti
Journal:  Leukemia       Date:  2015-05-18       Impact factor: 11.528

7.  Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease.

Authors:  G Biolcati; C Aurizi; L Barbieri; S Cialfi; I Screpanti; C Talora
Journal:  Clin Exp Dermatol       Date:  2013-10-25       Impact factor: 3.470

Review 8.  ATP2C1 gene mutations in Hailey-Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking.

Authors:  M Micaroni; G Giacchetti; R Plebani; G G Xiao; L Federici
Journal:  Cell Death Dis       Date:  2016-06-09       Impact factor: 8.469

9.  Yeast-Based Screen to Identify Natural Compounds with a Potential Therapeutic Effect in Hailey-Hailey Disease.

Authors:  Graziella Ficociello; Azzurra Zonfrilli; Samantha Cialfi; Claudio Talora; Daniela Uccelletti
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

10.  The loss of ATP2C1 impairs the DNA damage response and induces altered skin homeostasis: Consequences for epidermal biology in Hailey-Hailey disease.

Authors:  Samantha Cialfi; Loredana Le Pera; Carlo De Blasio; Germano Mariano; Rocco Palermo; Azzurra Zonfrilli; Daniela Uccelletti; Claudio Palleschi; Gianfranco Biolcati; Luca Barbieri; Isabella Screpanti; Claudio Talora
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.